Notes
CDC. Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR November 2005; 54 (No. RR-12): 4–5.
2Adapted from: CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR December 2005; 54 (No. RR-17): 4–5; CDC. Core curriculum on Tuberculosis: What the clinician should know. 4th ed. Atlanta, GA: US Department of Health and Human Services, CDC, 2000; CDC. Guide for primary health care providers: Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR June 2000; 49 (No. RR-6): 7–9.
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection—United States, 2010. MMWR 2010; 59 (RR-5); 1–25.
Guide for Primary Health Care Providers: Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. www.cdc.gov/tb/pubs/LTBI/treatment.htm.
Official ATS Statement: Hepatotoxicity of Antiuberculosis Therapy, Am J Respir Crit Care Med, vol 174, pp 935–952, 2006.